Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine MEAC90 for Interscalene Block
NCT04833296Phase 4Unknown
- Sponsor
- Healthpoint
- Start
- May 2021
- Primary completion
- Sep 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine in postoperative pain, sponsored by Healthpoint. Status: unknown.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04833296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04833296.